Guru Ownership Trend
Guru Analysis for Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.54 M.
Top institutional holders include Steven Cohen and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $38.51 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 572.7%. Conversely, Cliff Asness reduced exposure by 3.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Beta Bionics, Inc. (BBNX)
Major holders include Steven Cohen ($30.08 M), Paul Tudor Jones ($7.91 M), First Eagle Investment ($7.73 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.55 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $38.51 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited BBNX. The total reported sell value was $495,979.34.
Yes, 2 managers opened new positions in BBNX, and 2 increased their existing holdings. The total reported buy value was $39.01 M.